A new Selective Metabotropic Glutamate Receptor type 4 Agonist Reveals New ways to Develop Subtype Selective Orthosteric Ligands with Potential Therapeutic Effects

Cyril Goudet (1) , Bruno Vilar (1) , Tiphanie Courtiol (2) , Thierry Deltheil (3) , Thomas Bessiron (4) , Isabelle Brabet (1) , Nadia Oueslati (5) , Delphine Rigault (2) , Hugues-Olivier Bertrand (6) , Heather Mclean (4) , Hervé Daniel (4) , Marianne Amalric (3) , Francine C. Acher (2) , Jean-Philippe Pin (1)

1 IGF - Institut de Génomique Fonctionnelle
2 LCBPT - UMR 8601 - Laboratoire de Chimie et de Biochimie Pharmacologiques et Toxicologiques
3 LNC - Laboratoire de Neurosciences Cognitives [Marseille]
4 IBBMC - Institut de biochimie et biophysique moléculaire et cellulaire
5 Cisbio Bioassays
6 Accelrys SARL

no abstract

Domaines: Sciences cognitives; Neurosciences

Cyril Goudet, Bruno Vilar, Tiphanie Courtiol, Thierry Deltheil, Thomas Bessiron, et al.. A new Selective Metabotropic Glutamate Receptor type 4 Agonist Reveals New ways to Develop Subtype Selective Orthosteric Ligands with Potential Therapeutic Effects. Current Neuropharmacology, 2011, 9 (1), pp.26. ⟨hal-01384798⟩